George Soros's position in Sarepta Therapeutics is currently worth $8.43 Million. That's 0.27% of their equity portfolio (80th largest holding). The first Sarepta Therapeutics trade was made in Q3 2012. Since then George Soros bought shares nine more times and sold shares on six occasions. The investor's estimated purchase price is $31.6 Million, resulting in a loss of 73%.